Adherence to Pentavalent Rotavirus Vaccine (RV5) 3-Dose Schedule

Basic Details
Date Posted
Wednesday, October 21, 2020
Status
Complete
Medical Product
3-dose rotavirus vaccination
RotaTeq
Health Outcome(s)
adherence
Description

This request identified oral dose administrations of Pentavalent Rotavirus Vaccine (RV5) among infants with a birth date in the Sentinel Distributed Database (SDD) and assessed adherence measures per guidelines set by the Food and Drug Administration (FDA) and the Advisory Committee on Immunization Practices (ACIP). 

The study included infants with birth dates from January 1, 2014 to December 31, 2017. We distributed this request on September 30, 2019 to seven Data Partners contributing to the SDD.

 

Additional Details
FDA Center
CBER
Time Period
January 1, 2014 to December 31, 2018
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
Infants
Data Sources
Sentinel Distributed Database (SDD)